Proficio Capital Partners LLC Makes New Investment in The Cooper Companies, Inc. (NASDAQ:COO)

Proficio Capital Partners LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 94,504 shares of the medical device company's stock, valued at approximately $95,000.

Several other hedge funds have also added to or reduced their stakes in COO. JPMorgan Chase & Co. lifted its stake in Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock valued at $543,979,000 after buying an additional 573,908 shares during the period. Swedbank AB lifted its stake in Cooper Companies by 14.0% in the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company's stock valued at $149,809,000 after buying an additional 200,000 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after buying an additional 194,118 shares during the period. Soros Fund Management LLC acquired a new stake in shares of Cooper Companies during the third quarter worth about $19,310,000. Finally, Champlain Investment Partners LLC raised its position in shares of Cooper Companies by 8.0% during the third quarter. Champlain Investment Partners LLC now owns 1,818,345 shares of the medical device company's stock worth $200,636,000 after purchasing an additional 134,875 shares during the period. Institutional investors own 24.39% of the company's stock.

Remove Ads

Cooper Companies Stock Up 4.5 %

COO stock traded up $3.49 during mid-day trading on Friday, reaching $81.22. The company had a trading volume of 2,436,699 shares, compared to its average volume of 1,255,328. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The stock has a 50 day simple moving average of $91.20 and a two-hundred day simple moving average of $98.86. The company has a market capitalization of $16.24 billion, a price-to-earnings ratio of 41.65, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $77.05 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on COO. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Wells Fargo & Company raised their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, December 6th. Finally, Morgan Stanley dropped their target price on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $111.89.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.